Growth in 340B sales is being driven by specialty products and use of mail-order contract pharmacy, pharmacy consulting firm IQVIA says.

340B Sales Grew 18% from 2019 to 2020, Drug Industry Consulting Firm Says

Drug industry consulting and contract research firm IQVIA reports that prescription drug sales at 340B-discounted prices grew 18.1% year-on-year from 2019 to 2020.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »